← brief for 2026-09-25 · Slowing decline

An RNA thermogenic therapy to preserve lean mass and enhance metabolic health during GLP-1 weight loss.

Article D Peer reviewed Preclinical

Key takeaways

This study tested a new RNA therapy in animals and cells, not in people yet. It aims to help keep muscle mass when people lose weight with GLP-1 drugs. The results are promising in the lab but need human trials to confirm.

Who did this work

Thorne AK · Waldeck NJ · Rose JP · Stachowski MJ · Guak H · Keeble AR · Kuusik B · Simon E · Marcheva B · Mastroni JV · Zhu P · Chong LW

Source

Article · PubMed, the drug frontier · 2026 Sep 25
https://pubmed.ncbi.nlm.nih.gov/42789307/